Press release
Wulkowicz Family Honored as Adoption Family of the Year
San Bernardino. CA - The Department of Social Serices, proudly announces the Wulkowicz Family as the recipients of the 2025 Adoption Family of the Year award. This prestigious honor recognizes families who exemplify extraordinary commitment, love, and advocacy for adoption.
The Wulkowicz Family has been a beacon of inspiration in the adoption community, opening their home and hearts to Special Needs Children and adopted 7 children over the past 13 years. Soon an adoption will be finalized for child number 8. Their journey is marked by unwavering compassion, resilience, and dedication to ensuring every child in their care has the opportunity to thrive.
"Families like the Wulkowiczes' remind us of the transformative power of love and the vital importance of adoption," "They are not just providing a home; they are creating a foundation of stability, care, and opportunity for their children to flourish."
The Wulkowicz Family's advocacy extends beyond their home. Their efforts have raised awareness about the importance of adoption and inspired countless others to consider opening their homes to children in need.
"We are deeply honored to receive this recognition," said John Wulkowicz "Adoption has been an incredible journey for our family. Each child brings their own unique joy, and we are grateful for the opportunity to provide them with the love and support they deserve."
The Adoption Family of the Year award was presented to the Wulkowicz Family during a special ceremony. The event celebrates the contributions of adoptive families and highlight the importance of adoption in building strong and loving communities.
A Go Fund Me account is available for donations. Please go to https://gofund.me/d262e309 If anyone needs a tax write off, the family can use a custom built large home for their special needs children. Thank you for your time and consideration.
Media Contact
Company Name: John Wulkowicz
Contact Person: John Wulkowicz
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=wulkowicz-family-honored-as-adoption-family-of-the-year]
Country: United States
Website: https://gofund.me/d262e309
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Wulkowicz Family Honored as Adoption Family of the Year here
News-ID: 3755350 • Views: …
More Releases from ABNewswire
Myelofibrosis Market Outlook 2034 - Clinical Trials, Market Size, Medication, Pr …
Myelofibrosis Market Include Incyte Corporation, Keros Therapeutics, Karyopharm Therapeutics, Celgene Corporation, PharmaEssentia, Novartis, SecuraBio, Pharmaxis, Novartis Oncology, AstraZeneca, Cellenkos, Jacobio Pharmaceuticals, Ohmoncology, Geron Corporation, AbbVie, Sierra Oncology, Galecto Biotech, Actuate Therapeutics, Kartos Therapeutics, Menarini Group, Telios Pharma, Novartis Pharmaceuticals, NS Pharma, Celgene/Bristol-Myers Squibb, MorphoSys, Imago BioSciences, Roche, and others.
Myelofibrosis Market Summary
The Myelofibrosis market in the 7MM is set to grow significantly, rising from USD 2.6 billion in 2025 to USD…
Kid Connecticut Showcases Full Catalog of Authentic Innovation
Rising independent artist Kid Connecticut is making waves across streaming platforms with a catalog that blends sharp lyricism, genre-bending production, and unfiltered authenticity. With every release, Kid Connecticut has built a reputation as a creator who refuses to follow the industry blueprint. Instead, he offers listeners a body of work that reflects growth, resilience, and originality while capturing the reality of an artist evolving in real time.
From his earliest tracks…
Adeno-Associated Virus (AAV) Vectors in Gene Therapy Pipeline 2025: Innovations …
Adeno-Associated Virus (AAV) Vectors in Gene Therapy companies are Nanoscope Therapeutics, REGENXBIO, Astellas Gene Therapy, GeneCradle Therapeutics, Asklepios BioPharmaceutical, 4D Molecular Therapeutics, Adverum Biotechnologies, Rocket Pharmaceuticals, Innostellar Biotherapeutics, Passage Bio, Aspa Therapeutics, Solid Biosciences, Lantu Biopharma, Ascidian Therapeutics, Decibel Therapeutics, Sio Gene Therapies, and others.
As the use of Adeno-Associated Virus (AAV) vectors in gene therapy expands globally, there is increasing demand for safer and more effective treatment options, addressing conditions…
Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) Market: …
The total market size of EGFR mNSCLC in the 7MM was ~USD 4,000 million in 2023.
Emerging EGFR-NSCLC therapies-such as TAGRISSO, GILOTRIF/GIOTRIF, TARCEVA, RYBREVANT, VIZIMPRO, IRESSA, PORTRAZZA, Aumolertinib, Zipalertinib, Furmonertinib, BDTX-1535, Dato-DXd, JIN-A02, NX-019, STX-721, and ORIC-11-are expected to drive market growth in the coming years.
DelveInsight's report, "Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) - Market Insights, Epidemiology, and Market Forecast-2034," provides a comprehensive analysis of EGFR-NSCLC, including historical…
